ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 64 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,603,000 | -33.8% | 712,651 | 0.0% | 0.00% | – |
| Q3 2017 | $2,423,000 | -4.2% | 712,651 | 0.0% | 0.00% | – |
| Q2 2017 | $2,530,000 | +4.4% | 712,651 | 0.0% | 0.00% | – |
| Q1 2017 | $2,423,000 | -26.1% | 712,651 | 0.0% | 0.00% | – |
| Q4 2016 | $3,278,000 | -1.4% | 712,651 | -9.1% | 0.00% | – |
| Q3 2016 | $3,325,000 | +76.7% | 784,091 | 0.0% | 0.00% | – |
| Q2 2016 | $1,882,000 | -56.4% | 784,091 | -14.6% | 0.00% | -100.0% |
| Q1 2016 | $4,316,000 | +13.0% | 918,325 | -5.5% | 0.00% | 0.0% |
| Q4 2015 | $3,821,000 | +1.6% | 972,165 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $3,762,000 | -16.9% | 972,165 | -1.2% | 0.00% | 0.0% |
| Q2 2015 | $4,525,000 | -31.6% | 983,665 | +0.3% | 0.00% | 0.0% |
| Q1 2015 | $6,611,000 | +108.7% | 980,865 | 0.0% | 0.00% | – |
| Q4 2014 | $3,168,000 | – | 980,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $7,144,000 | 0.82% |
| Northeast Financial Consultants Inc | 732,265 | $988,000 | 0.30% |
| Family Management Corp | 10,424 | $14,000 | 0.01% |
| LMR Partners LLP | 81,550 | $110,000 | 0.01% |
| ELEMENT CAPITAL MANAGEMENT LLC | 148,528 | $201,000 | 0.01% |
| Poehling Capital Management, INC. | 3,302 | $4,000 | 0.00% |
| Paloma Partners Management Co | 143,800 | $194,000 | 0.00% |
| Founders Capital Management | 3,000 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 186,254 | $251,000 | 0.00% |
| FNY Investment Advisers, LLC | 4,230 | $5,000 | 0.00% |